Kelsey Goodwin
Stock Analyst at Piper Sandler
Total Price Targets
9
Stocks Covered
7
Sectors
Healthcare
Most Recent
Jan 16, 2026
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Kelsey Goodwin
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| CGON | CG Oncology, Inc. Common stock | $70.00 | $66.29 | +5.6% | 2 | Jan 16, 2026 |
| JANX | Janux Therapeutics, Inc. | $30.00 | $14.35 | +109.1% | 1 | Jan 16, 2026 |
| BDTX | Black Diamond Therapeutics, Inc. | $8.00 | $2.60 | +208.3% | 1 | Jan 16, 2026 |
| ORIC | ORIC Pharmaceuticals, Inc. | $22.00 | $9.88 | +122.7% | 1 | Jan 7, 2026 |
| NUVL | Nuvalent, Inc. | $128.00 | $99.45 | +28.7% | 2 | Oct 27, 2025 |
| RVMD | Revolution Medicines, Inc. | $75.00 | $140.52 | -46.6% | 1 | Aug 19, 2025 |
| SMMT | Summit Therapeutics Inc. | $21.00 | $16.11 | +30.4% | 1 | Aug 19, 2025 |
Recent Activity
- Jan 16, 2026— Set$70.00price target onCGON(CG Oncology, Inc. Common stock)
- Jan 16, 2026— Set$30.00price target onJANX(Janux Therapeutics, Inc.)
- Jan 16, 2026— Set$8.00price target onBDTX(Black Diamond Therapeutics, Inc.)
- Jan 7, 2026— Set$22.00price target onORIC(ORIC Pharmaceuticals, Inc.)
- Oct 27, 2025— Set$128.00price target onNUVL(Nuvalent, Inc.)
- Aug 19, 2025— Set$21.00price target onSMMT(Summit Therapeutics Inc.)
- Aug 19, 2025— Set$55.00price target onCGON(CG Oncology, Inc. Common stock)
- Aug 19, 2025— Set$75.00price target onRVMD(Revolution Medicines, Inc.)
- Sep 16, 2024— Set$105.00price target onNUVL(Nuvalent, Inc.)
Frequently Asked Questions
Who is Kelsey Goodwin?
Kelsey Goodwin is a stock analyst at Piper Sandler covering 7 stocks primarily in Healthcare. They have issued 9 price targets since Sep 16, 2024.
What stocks does Kelsey Goodwin cover?
Kelsey Goodwin currently covers 7 stocks, including CGON, NUVL, JANX, BDTX, ORIC.
What is Kelsey Goodwin's latest price target?
Kelsey Goodwin's most recent price target was $70.00 on CGON (CG Oncology, Inc. Common stock), set on Jan 16, 2026.
What is Kelsey Goodwin's highest price target?
Kelsey Goodwin's highest issued price target is $128.00 on NUVL, set on Oct 27, 2025.
More Analysts at Piper Sandler
Coverage based on publicly published price targets. Not investment advice.